Healthcare Sep 16, 2022 11:10 PM (GMT+8)
NaviSeed (Chinese: 奈维医疗) completes tens of millions of CNY in Angel Round, which is led by Yuanming Capital (Chinese: 元明新兆源基金) exclusively.
Founded in April 2021, NaviSeed is an innovative technology medical enterprise focusing on minimally invasive cancer intervention. The core product of the company is the radioactive particle implantation robot system, which originated from the first domestic medical robot industrialization platform and was officially established in 2017. It is the first domestic project in this field. Starting from clinical needs and combining with clinical medical guidelines, the project builds a tumor minimally invasive intervention technology platform and prepares for clinical trials.